NIH Awards $1.7 Million Grant for Lupus Research
Researchers will focus on three main goals: identifying the genes directly controlled by ARID3a, understanding how the protein helps B cells break normal safety rules, and testing whether blocking ARID3a in mice can reduce lupus symptoms.
HHS Awards $102 Million to Expand Health Center Program
The HHS awards will support 158 new and existing health centers and expand access to primary care.
NIH Awards Cash Prizes to 15 Teams for Ideas That Integrate Diet and Nutrition in Autoimmune Disease Research
Fifteen scientific teams have been awarded cash prizes for their submissions to a national crowdsourcing challenge designed to generate innovative ideas that integrate diet and nutrition into autoimmune disease research.
Stanford Researchers Awarded $18 Million to Develop a Universal Vaccine
Stanford researchers will develop a universal vaccine platform that could protect against viruses such as influenza and COVID-19, in addition to allergens and bacteria that cause pneumonia.
NIH Launches $4 Million Study of Autoimmune Disease Causes
The new NIH study will hopefully identify the earliest biological triggers of autoimmune disease.
New Healthcare Advisory Committee Created to Improve Patient Care
The Healthcare Advisory Committee will develop actionable policy solutions, advance accountability for safety and more.
New CMS Proposal to Speed up Patient Access to Drugs
The new federal advisory body, the Healthcare Advisory Committee, will provide advice on modernizing healthcare in the U.S.
CMS Launches First Wave of HealthTech Ecosystem Tools
CMS has launched HealthTech tools to streamline care and digitize the patient experience.
CMS Proposes to Lower Costs for Hip, Knee and Ankle Replacements
A new CMS Comprehensive Care for Joint Replacement (CJR) Model proposal could lower costs nationwide for Medicare beneficiaries undergoing knee, hip and ankle replacements.
Researchers Awarded $900,000 Grant to Develop Drug to Fight Cancer
Wei Gao, PhD, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer Prevention and Research Institute of Texas to develop a stronger and more targeted anti-tumor therapy for pancreatic and lung cancer.